Inventor
RUAN FUQIANG
US26 patents
⚠️ This page may combine multiple inventors who share the name “RUAN FUQIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ICOS CORP
9 patentsUS7932260B2Apr 26, 2011
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP221 citations99
US8980901B2Mar 17, 2015
5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP39 citations98
US8586597B2Nov 19, 2013
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP36 citations98
USRE44599ENov 12, 2013
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP44 citations98
US8993583B2Mar 31, 2015
5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta
ICOS CORP22 citations96
US8779131B2Jul 15, 2014
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP30 citations96
US9149477B2Oct 6, 2015
5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP17 citations92
US10336756B2Jul 2, 2019
(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta
ICOS CORP5 citations84
US10906907B2Feb 2, 2021
Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof
ICOS CORP0 citations73
RUAN FUQIANG
3 patentsUS9637488B2May 2, 2017
Heterocyclic compounds as inhibitors of class I PI3KS
RUAN FUQIANG2 citations71
US8680151B2Mar 25, 2014
Compounds, compositions and methods for treating or preventing hypoxic or ischemic injury
RUAN FUQIANG2 citations58
US10442799B1Oct 15, 2019
Heterocyclic compounds and uses thereof
RUAN FUQIANG0 citations39
FOWLER KERRY W
2 patentsBIOMEMBRANE INST
2 patentsUS5391800AFeb 21, 1995
Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives
BIOMEMBRANE INST51 citations95
US5260288ANov 9, 1993
Method for inhibition of cell motility by sphingosine-1-phosphate and derivatives
BIOMEMBRANE INST51 citations95
BELLEROPHON BCM LLC
2 patents3 2 PHARMA LLC
2 patentsGENESIS MOLECULAR TECH INC
2 patentsUS12168665B2Dec 17, 2024
Substituted imidazo[l,2-a]pyrazines and pyrazino[l,2-a] pyrimidines as topical agents for dermatological applications
GENESIS MOLECULAR TECH INC0 citations57
US11639356B2May 2, 2023
Substituted imidazo[1,2-a]pyrazines and pyrazino[1,2-a]pyrimidines as topical agents for dermatological applications
GENESIS MOLECULAR TECH INC0 citations57